StockData
Elevance Health, Inc. logo

Elevance Health, Inc. (ELV) operating KPIs

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$420.07−1.95 (-0.46%)

Close on Oct 30, 2026Market cap $91.10BP/E 18.7Yield –

Elevance Health aFS Fixed Maturity by Maturity — Due in 1 Year or Less (Fair Value) ($M)

Quarterly figures from Elevance Health's filings and investor materials

QuarterlyAnnual
Latest, Q3 2026
289
Period ended Sep 30, 2026
Change on a year earlier
+3.6%
279 in Q3 2025
History
16 quarters
Since Q3 2022
Sources
3
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAFS Fixed Maturity by Maturity — Due in 1 Year or Less (Fair Value) ($M)Year on yearSource
Q3 2026Sep 30, 2026289+3.6%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q2 2026Jun 30, 2026272-7.5%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q1 2026Mar 31, 2026200+2.0%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q4 2025Dec 31, 2025238+21.4%ELV 10-K (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q3 2025Sep 30, 2025279+7.7%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q2 2025Jun 30, 2025294+49.2%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q1 2025Mar 31, 2025196-46.3%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q4 2024Dec 31, 2024196-58.3%ELV 10-K (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q3 2024Sep 30, 2024259-65.4%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q2 2024Jun 30, 2024197-82.4%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q1 2024Mar 31, 2024365-70.4%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q4 2023Dec 31, 2023470–ELV 10-K (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q3 2023Sep 30, 2023749-16.9%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q2 2023Jun 30, 20231,118–ELV 10-Q/A (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q1 2023Mar 31, 20231,232–ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q3 2022Sep 30, 2022901–ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗

Cite this data

StockData. (2026). Elevance Health AFS Fixed Maturity by Maturity — Due in 1 Year or Less (Fair Value) ($M), quarterly Q3 2022–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/inv_afs_maturity_within_1yr_fv

See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.